Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic Drug
Trial details
- Registry ID
- NCT06641076
- Phase
- Phase 3
Drug identity checked against registry records
Also recorded as M1095
| No regulatory events match this view.This does not mean no FDA events have occurred. |